We are live on
!
Find out more
Axsome Therapeutics
AXSM
AXSM
35 hedge funds and large institutions have $35.3M invested in Axsome Therapeutics in 2017 Q2 according to their latest regulatory filings, with 6 funds opening new positions, 8 increasing their positions, 13 reducing their positions, and 20 closing their positions.
New
Increased
Maintained
Reduced
Closed
17% more capital invested
Capital invested by funds: $30.2M → $35.3M (+$5.01M)
6.74% less ownership
Funds ownership: 33.86% → 27.12% (-6.7%)
29% less funds holding
Funds holding: 49 → 35 (-14)
38% less repeat investments, than reductions
Existing positions increased: 8 | Existing positions reduced: 13
70% less first-time investments, than exits
New positions opened: 6 | Existing positions closed: 20
Holders
35
Holders Change
-14
Holders Change %
-28.57%
% of All Funds
0.87%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
6
Increased
8
Reduced
13
Closed
20
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
SFM
Sphera Funds Management
Tel Aviv,
Israel
|
+$419K |
| 2 |
Millennium Management
New York
|
+$331K |
| 3 |
ECM
Element Capital Management
New York
|
+$257K |
| 4 |
PP
Paloma Partners
Greenwich,
Connecticut
|
+$205K |
| 5 |
LP
LMR Partners
London,
United Kingdom
|
+$157K |
Top Sellers
| 1 |
BlackRock
New York
|
-$1.86M |
| 2 |
NC
Nexthera Capital
New York
|
-$1.56M |
| 3 |
JP Morgan Chase
New York
|
-$670K |
| 4 |
OPPM
Opus Point Partners Management
New York
|
-$559K |
| 5 |
State Street
Boston,
Massachusetts
|
-$540K |
